1993
DOI: 10.2739/kurumemedj.40.153
|View full text |Cite
|
Sign up to set email alerts
|

Immature Teratoma of the Uterine Fundus.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
13
0

Year Published

2000
2000
2020
2020

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(13 citation statements)
references
References 11 publications
0
13
0
Order By: Relevance
“…Teratomas arising from the uterus are extremely rare: Since the first description of a uterine teratoma by Mann in 1929 there have been just a handful of case reports [5]. The majority of these are mature teratomas and there are only three previous reports in the literature of immature teratomas arising from the uterus [6-8]. All previous reports have been in women of reproductive age and to our knowledge this is the first report of a teratoma in a post-menopausal lady.…”
Section: Resultsmentioning
confidence: 99%
“…Teratomas arising from the uterus are extremely rare: Since the first description of a uterine teratoma by Mann in 1929 there have been just a handful of case reports [5]. The majority of these are mature teratomas and there are only three previous reports in the literature of immature teratomas arising from the uterus [6-8]. All previous reports have been in women of reproductive age and to our knowledge this is the first report of a teratoma in a post-menopausal lady.…”
Section: Resultsmentioning
confidence: 99%
“…Therefore, most of the evidence for stage I disease after surgical treatment is obtained from case reports. In these case reports, clinical observations were used to determine various treatment methods, and these included two cycles of chemotherapy vincristine, actinomycin-D, and cyclophosphamide (VAC), 2,4 an undescribed treatment regimen, 3 and radiotherapy (Table 1). 2-5 In addition, not all of the reports described patient follow-up and outcomes, thereby preventing a comparison of treatment decisions.…”
Section: Discussionmentioning
confidence: 99%
“… 2-5 In addition, not all of the reports described patient follow-up and outcomes, thereby preventing a comparison of treatment decisions. Iwanaga et al 4 reported a patient that received adjuvant treatment with VAC, and subsequently presented no evidence of tumor recurrence five years post-treatment.…”
Section: Discussionmentioning
confidence: 99%
“…As the benefit of adjuvant chemotherapy is not clearly established, surveillance can be a reasonable option [12]. Iwanaga et al reported a case of 36-year-old woman, treated by surgery followed by two courses of VAC chemotherapy regimen without evidence of recurrence five years postoperatively [7]. In the paper published by Ansah-Boateng et al, the patient was treated by hysterectomy followed by pelvic radiotherapy; she has remained well with no evidence of recurrence [8].…”
Section: Discussionmentioning
confidence: 99%